Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Puma Biotechnology (PBYI) over the last 5 years, with Dec 2024 value amounting to $0.62.

  • Puma Biotechnology's EPS (Weighted Average and Diluted) fell 58.54% to $0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.75, marking a year-over-year increase of 59.57%. This contributed to the annual value of $0.62 for FY2024, which is 37.78% up from last year.
  • Latest data reveals that Puma Biotechnology reported EPS (Weighted Average and Diluted) of $0.62 as of FY2024, which was up 37.78% from $0.45 recorded in FY2023.
  • In the past 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) ranged from a high of $0.62 in FY2024 and a low of -$1.52 during FY2020.
  • In the last 3 years, Puma Biotechnology's EPS (Weighted Average and Diluted) had a median value of $0.45 in 2023 and averaged $0.36.
  • Data for Puma Biotechnology's EPS (Weighted Average and Diluted) shows a peak YoY skyrocketed of 1,010,824.96% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Puma Biotechnology's EPS (Weighted Average and Diluted) stood at -$1.52 in 2020, then skyrocketed by 52.63% to -$0.72 in 2021, then soared by 100.01% to $0.00 in 2022, then spiked by 1,010,824.96% to $0.45 in 2023, then skyrocketed by 37.78% to $0.62 in 2024.